XJN010 nasal spray

· Guangzhou Novaken Pharm Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XJN010 nasal spray, covering 2025-09-05 to 2025-09-05. Get the full timeline:

Most recent: Clinical Trial Update: The Study is Being Conducted to Evaluate the Safety and Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing Off Episodes [Phase 2]

See pricing